The Shot Is Over. Say Hello To The Ozempic Pill
A new study reveals a swallowable capsule, BIONDD, that delivers GLP-1 drugs 119% more effectively than injections, heralding the end of the 'Ozempic shot'.
By Foodie Pundit Newsroom - Published - Updated - Section: Glp1 Weight Loss
Key points
- The era of injectable weight loss drugs may be ending, replaced by a daily pill that could be even more effective.
- This new technology removes the barrier of needle-phobia, potentially expanding the user base for GLP-1 drugs exponentially.
- The food and beverage industry is bracing for a massive demand shift towards smaller portions, lower-calorie options, and reduced alcohol consumption.
- Expect to see 'GLP-1 friendly' become the next major food marketing claim, influencing grocery aisles and restaurant menus.
This report is part of Foodie Pundit premium coverage. Foodie Pundit members read the full story. See membership.
Sources and methodology
Reported from primary records. Open any source to verify a claim.
More from the Foodie Pundit Newsroom
- Behind the Restaurant Contraction: Why National Chains Are Closing Hundreds of Locations
- Walmart Slammed With $23M Verdict in Whistleblower Retaliation Case
- NYC Latest Restaurant Openings Highlight Strategic Shifts in Hospitality Economics
- Global Wine Sales Face Structural Slowdown as Consumer Habits Shift
- Inside Peter Tempelhoff's Next Major Culinary Venture In Cape Town